患者决策援助对晚期喉癌患者的影响 - - 一项多中心研究
相关实验视频
Updated: Sep 17, 2025

07:30
Learning Modern Laryngeal Surgery in a Dissection Laboratory
Published on: March 18, 2020
8.2K
Anne N Heirman1,2, Japke F Petersen1, Abrahim Al-Mamgani3
1Department of Head-and-Neck Oncology and Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
BMC medical informatics and decision making
|July 2, 2025
概括
针对晚期喉癌的新型患者决策辅助器 (PDA) 显著降低了决策冲突,并改善了患者的知识. 该工具支持共享决策,使患者在复杂的治疗选择中获得权力.
科学领域:
- 在瘤学瘤学.
- 患者决策辅助工具 患者决策辅助工具
- 共享的决策方式
背景情况:
- 晚期喉癌给患者带来了复杂的治疗决策.
- 需要有效的工具来支持患者导航这些选择.
- 患者决策辅助器 (PDA) 可以促进知情决策.
研究的目的:
- 为患有晚期喉癌的患者开发和评估PDA.
- 评估PDA对决策冲突 (DC) 的影响.
- 测量患者知识和感知共享决策 (SDM) 的变化.
主要方法:
- 多中心前后研究设计 (NCT03292341,2016-2023).
- 纳入标准:没有远程转移的晚期喉癌.
- 干预组使用了PDA;对照组接受了通常的护理. 通过T1和T2的问卷测量结果.
主要成果:
- PDA组的总决策冲突得分明显较低 (调整后的平均差异为-32,p<0.001).
- 使用PDA的患者的知识得分显著更高 (69%对47%,p<0.001).
- 感知到的共享决策在干预组中更高 (平均78.16对70.32).
结论:
- 在晚期喉癌患者中,PDA有效降低了决策冲突.
- PDA显著提高了患者对治疗选择的了解.
- 该PDA改善了共享决策的感知,支持了患者的知情选择.
相关概念视频
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Nursing Ethical Principles II
1.4K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

